Multiplexed Immunoassay Diagnostics: Forward-Phase and Reverse-Phase Applications
Multiplexed assays for simultaneously detecting several biomarkers in a single sample are becoming popular in clinical diagnostic research. An advantage of multiplexing in diagnostics is that patterns of several biomarkers have better predictive value compared to detection of a single analyte using ELISAs. This web seminar presents, using an interactive format, the multiplexing platforms available for immunoassay diagnostics in this emerging market. The discussion will include the application of forward-phase and reverse-phase multiplexed immunoassays.

Multiplexing for Diagnostic Applications: Specific Immunoglobulin Analysis for Allergic and Autoimmune Diseases
Per Matsson, Ph.D., Chief Technology Officer, Phadia; Associate Professor, Uppsala University.

Other Presentations in this Webinar:

Multiple Analysis of Plasma Cytokines and Angiogenic Factors (CAFs) for Developing Predictive Markers
John Heymach, M.D., Ph.D., Associate Professor, Departments of Thoracic Head and Neck Medical Oncology and Cancer Biology,The University of Texas MD Anderson Cancer Center Clinical

Applications of the Reverse-Phase Protein Microarray for Multiplexed Protein Pathway Activation Mapping
Emanuel F. Petricoin III, Ph.D., Professor, Life Sciences & Company Director, Applied Proteomics and Molecular Medicine, George Mason University

Array-Based Multiplex Assay Fabrication
Antonia Holway, Ph.D., Director, Microarray Applications, Aushon BioSystems, Inc